Curriculum standards
Curriculum standards
Advanced Training in Neurology (Paediatrics & Child Health)
Knowledge guides
LG24: Movement disorders
Key presentations and conditions
Advanced Trainees will have a comprehensive depth of knowledge of these presentations and conditions.
Less common or more complex presentations and conditions
Advanced Trainees will understand these presentations and conditions.
Advanced Trainees will understand the resources that should be used to help manage patients with these presentations and conditions.
Epidemiology, pathophysiology, and clinical sciences
Advanced Trainees will have a comprehensive depth of knowledge of the principles of the foundational sciences.
Investigations, procedures, and clinical assessment tools
Advanced Trainees will know the scientific foundation of each investigation and procedure, including relevant anatomy and physiology. They will be able to interpret the reported results of each investigation or procedure.
Advanced Trainees will know how to explain the investigation or procedure to patients, families, and carers, and be able to explain procedural risk and obtain informed consent where applicable.
Important specific issues
Advanced Trainees will identify important specialty-specific issues and the impact of these on diagnosis and management and integrate these into care.
Presentations – hyperkinetic
- Ataxia
- Athetosis
- Ballismus
- Chorea
- Difficulty speaking and swallowing
- Dystonia
- Fasciculations
- Jitteriness
- Myokymia
- Stereotypies
- Tics
- Tremor
Presentations – hypokinetic
- Bradykinesia
- Catatonia
- Depression and/or mood changes
- Postural instability
Conditions – hyperkinetic
- Ataxia:
- acute cerebellar ataxia, including:
- acute cerebellitis
- episodic ataxias
- hereditary ataxia syndromes:
- ataxia with oculomotor apraxia:
- type 1
- type 2
- ataxia-telangiectasia
- dentatorubral-pallidoluysian atrophy
- Friedreich ataxia
- spinocerebellar ataxia
- ataxia with oculomotor apraxia:
- acute cerebellar ataxia, including:
- Cerebral palsy (CP)
- Chorea:
- benign hereditary chorea
- CP, including:
- secondary to hypoxic ischaemic encephalopathy
- glutaric aciduria
- Huntington disease
- metabolic abnormalities
- Sydenham chorea
- Wilson disease
- Dystonia:
- blepharospasm
- hemifacial spasm
- primary dystonias, such as:
- adolescent-onset dystonia of mixed type (DYT6)
- dopa responsive dystonia (Segawa disease)
- early-onset torsion dystonia (DYT1)
- myoclonus dystonia (DYT11)
- rapid-onset dystonia Parkinsonism (DYT12)
- secondary dystonia:
- acute dystonic reaction
- neuroleptic malignant syndrome
- oculogyric crisis
- serotonin syndrome
- status dystonicus
- Myoclonus:
- hyperekplexia
- myoclonic epilepsies
- primary myoclonic disorders:
- benign myoclonus of early infancy
- epileptic myoclonus of early infancy
- essential myoclonus
- myoclonus dystonia
- secondary myoclonic disorders
- startle epilepsy
- Other:
- baclofen withdrawal
- benign sleep myoclonus
- functional neurological disorders
- stereotypies
- Tourette syndrome and tic disorders
- Rett syndrome
- Tremor:
- drug-induced tremor
- essential tremor, and essential tremor plus
- metabolic / systemic causes of tremor
Conditions – hypokinetic
- Drug-induced Parkinsonism
- Functional neurological disorders
- Neurometabolic conditions
- Normal pressure hydrocephalus
- Progressive supranuclear palsy
- Sleep disorders, including:
- catatonia
- Structural brain abnormality
- Traumatic brain event:
- haemorrhage
- space-occupying lesion
- vascular
For each presentation and condition, Advanced Trainees will know how to:
Synthesise
- recognise the clinical presentation
- identify relevant epidemiology, prevalence, pathophysiology, and clinical science
- take a comprehensive clinical history
- conduct an appropriate examination
- establish a differential diagnosis
- plan and arrange appropriate investigations
- consider the impact of illness and disease on patients and their quality of life when developing a management plan
Manage
- provide evidence-based management
- prescribe therapies tailored to patients’ needs and conditions
- recognise potential complications of disease and its management, and initiate preventative strategies
- involve multidisciplinary teams
Consider other factors
- identify individual and social factors and the impact of these on diagnosis and management
Conditions
- Cervical dystonia
- Facial dystonia
- Neurotransmitters disease
- Niemann–Pick disease type C
- Palatal tremor
- Parkinsonian syndromes
- Paroxysmal dyskinesias
- Treatable neurometabolic movement disorders, such as:
- congenital folate deficiency
- glucose transporter 1 (GLUT1)
- vitamin E deficiency
For each presentation and condition, Advanced Trainees will know how to:
Synthesise
- recognise the clinical presentation
- identify relevant epidemiology, prevalence, pathophysiology, and clinical science
- take a comprehensive clinical history
- conduct an appropriate examination
- establish a differential diagnosis
- plan and arrange appropriate investigations
- consider the impact of illness and disease on patients and their quality of life when developing a management plan
Manage
- provide evidence-based management
- prescribe therapies tailored to patients’ needs and conditions
- recognise potential complications of disease and its management, and initiate preventative strategies
- involve multidisciplinary teams
Consider other factors
- identify individual and social factors and the impact of these on diagnosis and management
- Acute, chronic, common, and rare diseases that cause disorders of movement
- Neuroanatomy, neuropharmacology, and neurophysiology of the motor pathways
- Type of disorder, including:
- associated clinical features
- localisation
- time-course
Cerebrospinal fluid (CSF) procedures and investigations
- Lumbar puncture (LP) and interpretation of investigation results, such as:
- basic CSF analysis:
- cell count
- cytology
- folate
- immunological tests
- microbiological tests
- paired glucose level
- protein level
- opening pressure
- special tests:
- CSF neurotransmitters
- neopterin – CSF
- oligoclonal bands
- basic CSF analysis:
Clinical neurophysiology investigations
- EEG:
- sleep-deprived EEG
- standard EEG
- video EEG
Neurogenetic investigations
- Genetic testing, including, but not limited to:
- chromosomal testing, such as:
- karyotype
- microarray
- dystonia genes:
- DYT1
- DYT5
- DYT6
- DYT11
- DYT12
- genomic testing, including whole exome or genome sequencing
- mitochondrial genome sequencing
- targeted panel testing
- chromosomal testing, such as:
- Referral to a neurogeneticist
Neuroimaging investigations
- CT, including:
- CT angiography
- Functional imaging:
- functional MRI (fMRI)
- PET
- single photon emission computed tomography (SPECT)
- Magnetic resonance:
- angiography (MRA)
- spectroscopy (MRS)
- venogram (MRV)
- MRI
Neuroimmmunology investigations
- Anti-deoxyribonuclease B (anti-DNase B) titres
- Antistreptolysin O (ASO) titres
- Autoantibody measurement:
- anti-acetylcholine receptor antibodies
- anti-aquaporin 4 antibodies
- paraneoplastic antibodies
Neuropathology investigations
- Biopsy:
- brain
- muscle
Neuropsychological investigations
- Cognitive screening:
- Mini-Mental State Examination
- Referral to a neuropsychologist
Other investigations
- Cardiac investigations:
- 24-hour electrocardiogram monitoring
- ECG
- echocardiography
- Lung function tests:
- formal lung function tests
- vital capacity
- Other laboratory tests:
- acanthocytes
- alpha-fetoprotein
- B12 level
- ceruloplasmin
- coenzyme Q
- copper
- creatinine kinase
- drug screen
- fasting lipid profile
- IgG subclasses
- thrombophilia screen
- urinary porphyrins
- vitamin E
- Polysomnography
- Overlap with other allied health and medical specialties, such as:
- medical genetics
- physiotherapy
- rehabilitation medicine
- Prognosis and implications of these disorders